Latest From Omron Corp.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
The latest updates to the US Open Payments database show spending by device and diagnostics firms on physician royalties, consulting fees, education, research and more was a bit less in 2016 compared to 2015, but still substantial. Top "general payment" spending came from Medtronic, Zimmer Biomet, Johnson & Johnson, Stryker, Smith & Nephew and Intuitive Surgical; while top "research payments" were reported by Edwards Lifesciences, Boston Scientific, and Abbott Laboratories, according to the CMS database.
- Therapeutic Areas
- Omron Tateisi Electronics Co.
- Pacific Rim
- Parent & Subsidiaries
- Omron Corp.
- Senior Management
- Isao Ogino, Pres. & CEO
- Contact Info
Phone: (81) 75-344-7000
Shiokoji Horikawa, Shimogyo-ku
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.